• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体感染性疾病相关的自身抗体。

Human autoantibodies underlying infectious diseases.

机构信息

Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut national de la santé et de la recherche médicale, Necker Hospital for Sick Children, Paris, France.

Imagine Institute, Paris Cité University, Paris, France.

出版信息

J Exp Med. 2022 Apr 4;219(4). doi: 10.1084/jem.20211387. Epub 2022 Mar 23.

DOI:10.1084/jem.20211387
PMID:35319722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8952682/
Abstract

The vast interindividual clinical variability observed in any microbial infection-ranging from silent infection to lethal disease-is increasingly being explained by human genetic and immunological determinants. Autoantibodies neutralizing specific cytokines underlie the same infectious diseases as inborn errors of the corresponding cytokine or response pathway. Autoantibodies against type I IFNs underlie COVID-19 pneumonia and adverse reactions to the live attenuated yellow fever virus vaccine. Autoantibodies against type II IFN underlie severe disease caused by environmental or tuberculous mycobacteria, and other intra-macrophagic microbes. Autoantibodies against IL-17A/F and IL-6 are less common and underlie mucocutaneous candidiasis and staphylococcal diseases, respectively. Inborn errors of and autoantibodies against GM-CSF underlie pulmonary alveolar proteinosis; associated infections are less well characterized. In individual patients, autoantibodies against cytokines preexist infection with the pathogen concerned and underlie the infectious disease. Human antibody-driven autoimmunity can interfere with cytokines that are essential for protective immunity to specific infectious agents but that are otherwise redundant, thereby underlying specific infectious diseases.

摘要

在任何微生物感染中,个体间的临床差异巨大,从无症状感染到致命疾病都有,这种差异越来越多地可以用人类遗传和免疫决定因素来解释。中和特定细胞因子的自身抗体是导致相同感染性疾病的原因,就像相应细胞因子或反应途径的先天性错误一样。针对 I 型 IFNs 的自身抗体是导致 COVID-19 肺炎和减毒活黄热病疫苗不良反应的基础。针对 II 型 IFN 的自身抗体是导致由环境或结核分枝杆菌以及其他巨噬细胞内微生物引起的严重疾病的基础。针对 IL-17A/F 和 IL-6 的自身抗体则较为少见,分别与粘膜皮肤念珠菌病和葡萄球菌病有关。GM-CSF 的先天性错误和针对 GM-CSF 的自身抗体是导致肺泡蛋白沉积症的基础;相关感染的特征尚不明确。在个别患者中,针对细胞因子的自身抗体先于相关病原体感染存在,并导致感染性疾病。人类抗体驱动的自身免疫可以干扰对特定病原体保护性免疫至关重要但在其他方面是多余的细胞因子,从而导致特定的传染病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe24/8952682/2d47274a086d/JEM_20211387_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe24/8952682/2d47274a086d/JEM_20211387_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe24/8952682/2d47274a086d/JEM_20211387_Fig1.jpg

相似文献

1
Human autoantibodies underlying infectious diseases.人体感染性疾病相关的自身抗体。
J Exp Med. 2022 Apr 4;219(4). doi: 10.1084/jem.20211387. Epub 2022 Mar 23.
2
The ouroboros of autoimmunity.自身免疫的衔尾蛇。
Nat Immunol. 2024 May;25(5):743-754. doi: 10.1038/s41590-024-01815-y. Epub 2024 May 2.
3
Immunodeficiency secondary to anticytokine autoantibodies.细胞因子自身抗体导致的免疫缺陷。
Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):534-41. doi: 10.1097/ACI.0b013e3283402b41.
4
The Th17/IL-17 Axis and Host Defense Against Fungal Infections.辅助 T 细胞 17 细胞/白细胞介素 17 轴与宿主防御真菌感染。
J Allergy Clin Immunol Pract. 2023 Jun;11(6):1624-1634. doi: 10.1016/j.jaip.2023.04.015. Epub 2023 Apr 26.
5
Primary immunodeficiencies underlying fungal infections.导致真菌感染的原发性免疫缺陷病。
Curr Opin Pediatr. 2013 Dec;25(6):736-47. doi: 10.1097/MOP.0000000000000031.
6
Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.人类白细胞介素 17 免疫的先天缺陷是慢性黏膜皮肤念珠菌病的基础。
Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):616-22. doi: 10.1097/ACI.0b013e328358cc0b.
7
The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review.粒细胞-巨噬细胞集落刺激因子自身抗体在感染和自身免疫性肺泡蛋白沉积症中的作用:简要综述
Front Immunol. 2021 Nov 22;12:752856. doi: 10.3389/fimmu.2021.752856. eCollection 2021.
8
Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.抗白细胞介素-17A 自身抗体可能与 APECED 患者黏膜皮肤念珠菌病的严重程度相关。
J Clin Immunol. 2014 Feb;34(2):181-93. doi: 10.1007/s10875-014-9987-5. Epub 2014 Feb 4.
9
GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.肺泡蛋白沉积症中的粒细胞-巨噬细胞集落刺激因子自身抗体与中性粒细胞功能障碍
N Engl J Med. 2007 Feb 8;356(6):567-79. doi: 10.1056/NEJMoa062505.
10
Secondary immunodeficiencies related to the presence of anti-cytokine autoantibodies.与细胞因子自身抗体存在相关的继发性免疫缺陷。
Gac Med Mex. 2023;159(2):154-160. doi: 10.24875/GMM.M23000760.

引用本文的文献

1
Distinct circulating autoantibodies are associated with COVID-19 hospitalization and SARS-CoV-2 neutralization activity.不同的循环自身抗体与COVID-19住院治疗及SARS-CoV-2中和活性相关。
Npj Viruses. 2025 Sep 2;3(1):64. doi: 10.1038/s44298-025-00149-2.
2
Rheumatologic and Autoimmune Features of Inborn Errors of Immunity: Implications for Diagnosis and Management.免疫缺陷病的风湿性和自身免疫性特征:对诊断和管理的启示
J Hum Immun. 2025 Sep 1;1(3). doi: 10.70962/jhi.20250034. Epub 2025 Jul 23.
3
ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes.

本文引用的文献

1
Human genetic and immunological determinants of critical COVID-19 pneumonia.人类遗传和免疫因素决定新冠肺炎重症肺炎。
Nature. 2022 Mar;603(7902):587-598. doi: 10.1038/s41586-022-04447-0. Epub 2022 Jan 28.
2
Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital.法国一医院 20%的新冠肺炎死亡患者存在中和 I 型干扰素的自身抗体。
J Clin Immunol. 2022 Apr;42(3):459-470. doi: 10.1007/s10875-021-01203-3. Epub 2022 Jan 27.
3
Mechanisms of viral inflammation and disease in humans.人类病毒炎症和疾病的机制。
在健康个体中检测到的细胞间黏附分子-1自身抗体,并与功能性表位发生交叉反应。
Immunohorizons. 2025 May 30;9(7). doi: 10.1093/immhor/vlaf025.
4
Thymic Interferons: A Little Goes a Long Way.胸腺干扰素:小剂量却功效显著。
Immunol Rev. 2025 Jul;332(1):e70038. doi: 10.1111/imr.70038.
5
Rapid Detection of Anti-IFN-α2 Autoantibodies Using a New Automated VIDAS Assay Prototype.使用新型VIDAS自动检测原型快速检测抗IFN-α2自身抗体。
Eur J Immunol. 2025 Apr;55(4):e202451516. doi: 10.1002/eji.202451516.
6
Human type I interferons protect Vero E6 and ARPE-19 cells against West Nile virus and are neutralized by pathogenic autoantibodies.人I型干扰素可保护Vero E6细胞和ARPE - 19细胞免受西尼罗河病毒感染,并被致病性自身抗体中和。
Sci Rep. 2025 Apr 2;15(1):11271. doi: 10.1038/s41598-025-89312-6.
7
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design.I型干扰素自身抗体足迹揭示中和机制并助力抑制性诱饵设计。
J Exp Med. 2025 Jun 2;222(6). doi: 10.1084/jem.20242039. Epub 2025 Mar 20.
8
Case Report: Anti-interferon-γ autoantibodies in an adolescent with disseminated and mycobacterial co-infections.病例报告:一名患有播散性感染和分枝杆菌合并感染的青少年体内的抗干扰素-γ自身抗体
Front Pediatr. 2025 Feb 27;13:1552469. doi: 10.3389/fped.2025.1552469. eCollection 2025.
9
Autoimmunity against cytokines: Double strike in autoimmune disease, a historical perspective.针对细胞因子的自身免疫:自身免疫性疾病中的双重打击,历史视角
Biomedica. 2024 Dec 23;44(Sp. 2):209-219. doi: 10.7705/biomedica.7570.
10
The monogenic landscape of human infectious diseases.人类传染病的单基因格局。
J Allergy Clin Immunol. 2025 Mar;155(3):768-783. doi: 10.1016/j.jaci.2024.12.1078. Epub 2024 Dec 24.
Science. 2021 Nov 26;374(6571):1080-1086. doi: 10.1126/science.abj7965. Epub 2021 Nov 25.
4
Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19.恢复期血浆疗法治疗 COVID-19 中的干扰素-α2 自身抗体。
J Clin Immunol. 2022 Feb;42(2):232-239. doi: 10.1007/s10875-021-01168-3. Epub 2021 Nov 12.
5
The intersection of COVID-19 and autoimmunity.COVID-19 与自身免疫的交集。
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI154886.
6
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.在一个深度表型年轻患者队列中鉴定 COVID-19 危急型的驱动基因。
Sci Transl Med. 2022 Jan 19;14(628):eabj7521. doi: 10.1126/scitranslmed.abj7521.
7
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona.巴塞罗那 ICU 收治的 COVID-19 患者中,近 10% 患者预先存在中和高浓度 I 型干扰素的自身抗体。
J Clin Immunol. 2021 Nov;41(8):1733-1744. doi: 10.1007/s10875-021-01136-x. Epub 2021 Sep 27.
8
Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".评论“异常的 1 型免疫驱动黏膜真菌感染易感性”。
Science. 2021 Sep 17;373(6561):eabi6235. doi: 10.1126/science.abi6235. Epub 2021 Sep 16.
9
Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".评论“异常的 1 型免疫驱动黏膜真菌感染易感性”。
Science. 2021 Sep 17;373(6561):eabi5459. doi: 10.1126/science.abi5459. Epub 2021 Sep 16.
10
New-onset IgG autoantibodies in hospitalized patients with COVID-19.新型冠状病毒肺炎住院患者新出现的IgG自身抗体
Nat Commun. 2021 Sep 14;12(1):5417. doi: 10.1038/s41467-021-25509-3.